Paid Clinical Trial For Patients 18+ With Moderate to Severe Knee Pain Due To Osteoarthritis
To advance our understanding of knee pain due to osteoarthritis and find better treatments, clinical research is essential.
You can play a vital role.
We are currently recruiting for A phase 2, a randomized study to evaluate the efficacy and safety of intra-articular Investigational product to treat moderate to severe pain from knee osteoarthritis (OA). The active comparator is Zilretta.
Paid Clinical Trial For Patients 18+ With Moderate to Severe Knee Pain Due To Osteoarthritis
To advance our understanding of knee pain due to osteoarthritis and find better treatments, clinical research is essential.
You can play a vital role.
We are currently recruiting for A phase 2, a randomized study to evaluate the efficacy and safety of intra-articular Investigational product to treat moderate to severe pain from knee osteoarthritis (OA). The active comparator is Zilretta.
Who is eligible?
Not everyone can participate in a Clinical Trial. Clinical Trials have stringent criteria which must be met before eligibility is confirmed. Criteria include disease status, specific blood results, prior treatments, and therapies used.
Inclusion Criteria
- Adult ≥ 18 years of age with a BMI < 50 kg/m
- Moderate to severe pain in the index knee due to OA (≥ 6 months prior to Screening)
- Worst average daily pain of ≥ 4 (0-10 NRS) during the week prior to Screening
- Knee x-ray or MRI scan with KL grade ≥ 2 (within 3 months prior to Screening)
- Treatment failure/inadequate response with at least 2 prior analgesic agents (at least 1 NSAID)
- Willing to abstain from other IA injections/ knee surgery for at least 6 months after study treatment, unless elects early discontinuation from the study.
- If on any analgesic medications, must have been taking a stable dose for at least 1 month prior to screening with no increase in dose leading up to study treatment. If the subject is on “as needed” or PRN analgesic medications, these may be continued during the study.
Exclusion Criteria
- Intra-articular injection within one month of Screening
- Intra-articular injection with long acting steroid within three months of screening
- Any evidence of Serious coagulopathy
- History of the hemorrhagic event within 6 months prior to screening
- History of surgical hardware or other foreign bodies within the index knee joint. Hardware in the contralateral knee joint is permitted.
- Instability or misalignment in the index joint post-repair
- History of peripheral sensory neuropathy
- If on opioids, the upper limit of allowed opioids is 30mg/day Morphine equivalent.
- Substance use disorder
- Be pregnant at Screening or planning on becoming pregnant or are currently breastfeeding
- Have known human immunodeficiency virus or acquired immunodeficiency syndrome-related illness, acute or history of chronic hepatitis B or C, or positive serology tests for these conditions
If you meet the above inclusive and exclusion criteria and want to be part of this trial, please click the button below to register.
Who is eligible?
Not everyone can participate in a Clinical Trial. Clinical Trials have stringent criteria which must be met before eligibility is confirmed. Criteria include disease status, specific blood results, prior treatments, and therapies used.
Inclusion Criteria
- Adult ≥ 18 years of age with a BMI < 50 kg/m
- Moderate to severe pain in the index knee due to OA (≥ 6 months prior to Screening)
- Worst average daily pain of ≥ 4 (0-10 NRS) during the week prior to Screening
- Knee x-ray or MRI scan with KL grade ≥ 2 (within 3 months prior to Screening)
- Treatment failure/inadequate response with at least 2 prior analgesic agents (at least 1 NSAID)
- Willing to abstain from other IA injections/ knee surgery for at least 6 months after study treatment, unless elects early discontinuation from the study.
- If on any analgesic medications, must have been taking a stable dose for at least 1 month prior to screening with no increase in dose leading up to study treatment. If the subject is on “as needed” or PRN analgesic medications, these may be continued during the study.
Exclusion Criteria
- Intra-articular injection within one month of Screening
- Intra-articular injection with long acting steroid within three months of screening
- Any evidence of Serious coagulopathy
- History of the hemorrhagic event within 6 months prior to screening
- History of surgical hardware or other foreign bodies within the index knee joint. Hardware in the contralateral knee joint is permitted.
- Instability or misalignment in the index joint post-repair
- History of peripheral sensory neuropathy
- If on opioids, the upper limit of allowed opioids is 30mg/day Morphine equivalent.
- Substance use disorder
- Be pregnant at Screening or planning on becoming pregnant or are currently breastfeeding
- Have known human immunodeficiency virus or acquired immunodeficiency syndrome-related illness, acute or history of chronic hepatitis B or C, or positive serology tests for these conditions
If you meet the above inclusive and exclusion criteria and want to be part of this trial, please click the button below to register.
Who are we?
Our Clinical Research Center
OtriMed Research is a dedicated, physician-owned clinical research center whose goal is to identify and conduct the highest quality, innovative and safe clinical research studies in collaboration with established pharmaceutical companies in the USA/WorldWide to benefit the local community.
At OtriMed, we coordinate all phases of clinical and device-related trials. We focus on identifying only eligible subjects to minimize screen failures.
Who are we?
Our Clinical Research Center
OtriMed Research is a dedicated, physician-owned clinical research center whose goal is to identify and conduct the highest quality, innovative and safe clinical research studies in collaboration with established pharmaceutical companies in the USA/WorldWide to benefit the local community.
At OtriMed, we coordinate all phases of clinical and device-related trials. We focus on identifying only eligible subjects to minimize screen failures.
OUR TEAM
OUR TEAM
Dr. Pragya B. Gupta
MEDICAL DIRECTOR
American Board certified Anesthesiologist, who holds Sub Specialty certification in Pain Medicine and is also an American Academy of Pain Medicine certified pain specialist.
Dr. Robert E. Hurd
DOCTOR
Dr. Hurd is a graduate of Creighton University School of Medicine in Omaha, Nebraska, and is a board-certified internist and endocrinologist.
Jennifer Dehner, APRN
RESEARCH
Ryan Vogt-Foster
CLINICAL SOCIAL WORKER
Ryan Vogt-Foster, MSW, LCSW, has been delivering services for social service and mental health agencies for the past 11 years.
Dr. Pragya B. Gupta
MEDICAL DIRECTOR
American Board certified Anesthesiologist, who holds Sub Specialty certification in Pain Medicine and is also an American Academy of Pain Medicine certified pain specialist.
Dr. Robert E. Hurd
DOCTOR
Dr. Hurd is a graduate of Creighton University School of Medicine in Omaha, Nebraska, and is a board-certified internist and endocrinologist.
Jennifer Dehner, APRN
RESEARCH
Ryan Vogt-Foster
CLINICAL SOCIAL WORKER
Ryan Vogt-Foster, MSW, LCSW, has been delivering services for social service and mental health agencies for the past 11 years.
How do Clinical Trials work??
Small Call to Action HA clinical trial is a research study to determine the efficacy and safety of a new medicine or treatment modality.
In a clinical trial, researchers enroll volunteers based on study guidelines to evaluate a medical, surgical, or behavioral intervention and report results to a drug sponsor company, which then analyzes all data collected throughout the study.
What happens next?
Once you have completed the registration form and provided us with your preferred date and time for a call, one of our team members will be in touch to discuss study options.
How do Clinical Trials work??
Small Call to Action HA clinical trial is a research study to determine the efficacy and safety of a new medicine or treatment modality.
In a clinical trial, researchers enroll volunteers based on study guidelines to evaluate a medical, surgical, or behavioral intervention and report results to a drug sponsor company, which then analyzes all data collected throughout the study.
What happens next?
Once you have completed the registration form and provided us with your preferred date and time for a call, one of our team members will be in touch to discuss study options.
STRATEGIC LOCATION
Otrimed is located within one mile of St. Elizabeth Hospital & its emergency department. It is 7 miles from the Northern Kentucky - Cincinnati (Ohio) International Airport.
The clinical trial site is attached to the Advanced Pain Treatment Center, a full-time physician's office.
162 Barnwood Drive, Edgewood, KY 41017
Privacy Policy
STRATEGIC LOCATION
Otrimed is located within one mile of St. Elizabeth Hospital & its emergency department. It is 7 miles from the Northern Kentucky - Cincinnati (Ohio) International Airport.
The clinical trial site is attached to the Advanced Pain Treatment Center, a full-time physician's office.
162 Barnwood Drive, Edgewood, KY 41017
Privacy Policy